Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people

Area of Science:

• Cardiology
• Infectious Diseases
• Geriatrics

Background:

• COVID-19 poses a severe global health threat, with elderly individuals and those with comorbidities facing higher risks of mortality.
• Cardiovascular complications, including myocardial injury and thromboembolism, are prevalent in COVID-19 patients.
• Biomarkers like troponin, NTproBNP, and D-Dimer indicate disease severity and prognosis.

Purpose of the Study:

• To review the complex interplay between COVID-19 and the cardiovascular system in the elderly population.
• To explore supportive treatments for COVID-19 in older adults.
• To address concerns related to comorbidities and polypharmacotherapy in this demographic.

Main Methods:

• Literature review focusing on COVID-19, cardiovascular disease, and the elderly.
• Analysis of prognostic biomarkers and their significance.
• Examination of current supportive care strategies and challenges.

Main Results:

• Elderly patients with comorbidities exhibit elevated risks of severe COVID-19 and cardiovascular complications.
• Specific biomarkers are crucial for assessing prognosis in COVID-19 cases.
• Management of COVID-19 in the elderly requires careful consideration of existing conditions and medications.

Conclusions:

• COVID-19 significantly impacts the cardiovascular health of the elderly, exacerbating risks associated with pre-existing conditions.
• Effective management necessitates a comprehensive approach addressing both viral infection and cardiovascular sequelae.
• Further research into tailored supportive therapies is essential for improving outcomes in this vulnerable population.